Function preserving surgery of limb sarcomas: history and improvements;Chirurgie des sarcomes des tissus mous des membres chez l'adulte : historique et avancées thérapeutiques

Cancer/Radiotherapie

Volumn 10, Issue 6-7, 2006, Pages 416-424

  Bonvalot, S ^a   Missana, M C ^a   Le Cesne, A ^a   Missenard, G ^a   Vanel, D ^a   Terrier, P ^a   Le Pechoux C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Isolated limb perfusion; Sarcoma; Surgery; TNF

Indexed keywords

ANTHRACYCLINE; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; DEPRESSION; HAIR LOSS; HUMAN; LEG; LUNG EDEMA; MELANOMA; NAUSEA; PLASTIC SURGERY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; SHOCK; SHORT SURVEY; SKIN TOXICITY; SOFT TISSUE SARCOMA; SURGICAL TECHNIQUE; TUMOR BIOPSY; ADJUVANT CHEMOTHERAPY; ARM; LIMB SALVAGE; METHODOLOGY; REVIEW; SARCOMA; SURGERY;

ARM; CHEMOTHERAPY, ADJUVANT; HUMANS; LEG; LIMB SALVAGE; SARCOMA; SURGICAL PROCEDURES, OPERATIVE;

EID: 33750492907     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.05.015     Document Type: Short Survey

References (54)

1. Bonvalot S., Laplanche A., Lejeune F., Stoeckle E., Le Pechoux C., Vanel D., et al. Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNFα be better?. Ann. Oncol. 16 (2005) 1061-1068
2. Bonvalot S, Vanel D, Terrier P, Le Pechoux C, Le Cesne A. Principes du traitement des sarcomes des tissus mous de l'adulte. Encyclopédie Médico Chirurgicale. Traité de techniques chirurgicales-orthopédie-traumatologie 44-099, 521-542, 2004.
3. Bonvalot S., Kolb F., Mamlouk K., Cavalcanti A., Le Pechoux C., Terrier P., et al. Free-flap reconstruction of locally advanced soft tissue sarcomas. Ann. Chir. 126 (2001) 308-313
4. Bell R.S., O'Sullivan B., Liu F.F., Powell J., Langer F., Fornasier V.L., et al. The surgical margin in soft-tissue sarcoma. J. Bone Joint Surg. Am. 71 (1989) 370-375
5. Billingsley K.G., Lewis J.J., Leung D.H., Casper E.S., Woodruff J.M., and Brennan M.F. Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma. Cancer 15 (1999) 389-395 (85)
6. Carswell E.A., Old L.J., Kassel R.L., Green S., Fiore N., and Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72 (1975) 3666-3670
7. Clark M.A., Fisher C., Judson I., and Thomas J.M. Soft-tissue sarcomas in adults. N. Engl. J. Med. 353 (2005) 701-711
8. Coindre J.M., Terrier P., Bui N.B., Bonichon F., Collin F., Le Doussal V., et al. Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J. Clin. Oncol. 14 (1996) 869-877
9. Creech O., Krementz E.T., Ryan R.F., and Winblad J.N. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann. Surg. 148 (1958) 616-632
10. Davis A.M., Kandel R.A., Wunder J.S., Unger R., Meer J., O'Sullivan B., et al. The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J. Surg. Oncol. 66 (1997) 81-87
11. DeLaney T.F., Spiro I.J., Suit H.D., Gebhardt M.C., Hornicek F.J., Mankin H.J., et al. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 1117-1127
12. Disa J.J., and Hu Q.Y. Hidalgo. Retrospective review of 400 consecutive free flap reconstructions for oncologic surgical defects. Ann. Surg. Oncol. 4 (1997) 663-669
13. Edmonson J.H., Petersen I.A., Shives T.C., Mahoney M.R., Rock M.G., Haddock M.G., et al. Chemotherapy, irradiation, and surgery for function-preserving therapy of primary extremity soft tissue sarcomas: initial treatment with ifosfamide, mitomycin, doxorubicin, and cisplatin plus granulocyte macrophage-colony-stimulating factor. Cancer 94 (2002) 786-792
14. Enneking W.F. A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res. 204 (1986) 9-24
15. Eggermont A.M., Schraffordt Koops H., Klausner J.M., Kroon B.B., Schlag P.M., Lienard D., et al. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas.The cumulative multicenter European experience. Ann. Surg. 224 (1996) 756-764
16. Eggermont A.M., de Wilt J.H., and ten Hagen T.L. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol. 4 (2003) 429-437
17. Fiore M., Casali P.G., Miceli R., Mariani L., Bertulli R., Lozza L., et al. Prognostic effect of re-excision in adult soft tissue sarcoma of the extremity. Ann. Surg. Oncol. 13 (2006) 110-117
18. Fleming J.B., Berman R.S., Cheng S.C., Chen N.P., Hunt K.K., Feig B.W., et al. Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J. Clin. Oncol. 17 (1999) 2772-2780
19. Fraker D.L. Management of in-transit melanoma of the extremity with isolated limb perfusion. Curr. Treat. Options Oncol. 5 (2004) 173-184
20. Ghert M.A., Davis A.M., Griffin A.M., Alyami A.H., White L., Kandel R.A., et al. The surgical and functional outcome of limb-salvage surgery with vascular reconstruction for soft tissue sarcoma of the extremity. Ann. Surg. Oncol. 12 (2005) 1102-1110
21. Giuliano A.E., and Eilber F.R. The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J. Clin. Oncol. 3 (1985) 1344-1348
22. Gortzak E., Azzarelli A., Buesa J., Bramwell V.H., van Coevorden F., van Geel A.N., et al. EORTC Soft Tissue Bone Sarcoma Group and the NCI of Canada clinical Trials Group-Canadian Sarcoma Group. A randomised phase II study on neoadjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma. Eur. J. Cancer 37 (2001) 1096-1103
23. Grobmyer S.R., Maki R.G., Demetri G.D., Mazumdar M., Riedel E., Brennan M.F., et al. Neoadjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann. Oncol. 15 (2004) 1667-1672
24. Grunhagen D.J., de Wilt J.H., Graveland W.J., Verhoef C., van Geel A.N., and Eggermont A.M. Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcoma. Cancer 106 8 (2006) 1776-1784
25. Gustafson P., Dreinhofer K.E., and Rydholm A. Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop. Scand. 65 (1994) 47-50
26. Hahn G.M. Potential for therapy of drugs and hyperthermia. Cancer Res. 39 (1979) 2264-2268
27. Herbert S.H., Corn B.W., Solin L.J., Lanciano R.M., Schultz D.J., McKenna W.G., et al. Limb-preserving treatment for soft tissue sarcomas of the extremities. The significance of surgical margins. Cancer 72 (1993) 1230-1238
28. Hoeber I., Spillane A.J., Fisher C., and Thomas J.M. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann. Surg. Oncol. 8 (2001) 80-87
29. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics. Cancer J. Clin. 54 (2004) 8-29
30. Kraybill W.G., Harris J., Spiro I.J., Ettinger D.S., DeLaney T.F., Blum R.H., et al. Radiation Therapy Oncology Group Trial 9514. Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514. J. Clin. Oncol. 24 (2006) 619-625
31. Laurenzi L., Natoli S., Di Filippo F., et al. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNFα. J. Exp. Clin. Cancer Res. 23 (2004) 225-231
32. Le Pechoux C., Bonvalot S., Le Cesne A., Roberti E., Vanel D., Terrier P., et al. Place and technical aspects of external beam radiation therapy in the treatment of adult soft tissue sarcomas. Cancer Radiother. 10 (2006) 50-62
33. Lewis J.J., Leung D., Heslin M., Woodruff J.M., and Brennan M.F. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J. Clin. Oncol. 15 (1997) 646-652
34. Lienard D., Ewalenko P., Delmotte J.J., Renard N., and Lejeune F.J. High-dose recombinant tumor necrosis factor-alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J. Clin. Oncol. 10 (1992) 52-60
35. Noria S., Davis A., Kandel R., Levesque J., O'Sullivan B., Wunder J., et al. Residual disease following unplanned excision of soft-tissue sarcoma of an extremity. J. Bone Joint Surg. Am. 78 (1996) 650-655
36. O'Sullivan B., Davis A.M., Turcotte R., Bell R., Catton C., Chabot P., et al. Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359 (2002) 2235-2241
37. Pisters P.W., Leung D.H., Woodruff J., Shi W., and Brennan M.F. Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J. Clin. Oncol. 14 (1996) 1679-1689
38. Ray-Coquard I., Thiesse P., Ranchere-Vince D., Chauvin F., Bobin J.Y., Sunyach M.P., et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann. Oncol. 15 (2004) 307-315
39. Rosenberg S.A., Tepper J., Glatstein E., Costa J., Baker A., Brennan M., et al. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann. Surg. 196 (1982) 305-315
40. Siebenrock K.A., Hertel R., and Ganz R. Unexpected resection of soft-tissue sarcoma. More mutilating surgery, higher local recurrence rates, and obscure prognosis as consequences of improper surgery. Arch. Orthop. Trauma Surg. 120 (2000) 65-69
41. Sonneveld E.J., Vrouenraets B.C., van Geel B.N., Eggermont A.M., Klaase J.M., Nieweg O.E., et al. Systemic toxicity after isolated limb perfusion with melphalan for melanoma. Eur. J. Surg. Oncol. 22 (1996) 521-527
42. Stojadinovic A., Leung D.H., Hoos A., Jaques D.P., Lewis J.J., and Brennan M.F. Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann. Surg. 235 (2002) 424-434
43. Stojadinovic A., Jaques D.P., Leung D.H., Healey J.H., and Brennan M.F. Amputation for recurrent soft tissue sarcoma of the extremity: indications and outcome. Ann. Surg. Oncol. 8 (2001) 509-518
44. Stotter A.T., A'Hern R.P., Fisher C., Mott A.F., Fallowfield M.E., and Westbury G. The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival. Cancer 65 (1990) 1119-1129
45. Suit H.D., Russel W.O., and Martin R.G. Sarcoma of soft tissue: clinical and histopathologic parameters and response to treatment. Cancer 35 (1975) 1478-1483
46. Tanabe K.K., Pollock R.E., Ellis L.M., Murphy A., Sherman N., and Romsdahl M.M. Influence of surgical margins on outcome in patients with preoperatively irradiated extremity soft tissue sarcomas. Cancer 73 (1994) 1652-1659
47. Thijssens K.M., van Ginkel R.J., Pras E., Suurmeijer A.J., and Hoekstra H.J. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy. Ann. Surg. Oncol. 13 (2006) 518-524
48. Thompson J.F., and Gianoutsos M.P. Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J. Surg. 16 (1992) 227-233
49. Ueda T., Yoshikawa H., Mori S., et al. Influence of local recurrence on the prognosis of soft-tissue sarcomas. J. Bone Joint Surg. Br. 79 (1997) 553-557
50. Vrouenraets B.C., Klaase J.M., Nieweg O.E., and Kroon B.B. Toxicity and morbidity of isolated limb perfusion. Semin. Surg. Oncol. 14 (1998) 224-231
51. Vrouenraets B.C., Hart G.A., Eggermont A.M., Klaase J.M., van Geel B.N., Nieweg O.E., et al. Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J. Am. Coll. Surg. 188 (1999) 522-530
52. Wieberdink J., Benckhuysen C., Braat R.P., van Slooten E.A., and Olthuis G.A. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur. J. Cancer Clin. Oncol. 18 (1982) 905-910
53. Williard W.C., Hajdu S.I., Casper E.S., and Brennan M.F. Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity. Ann. Surg. 215 (1992) 269-275
54. Yang J.C., Chang A.E., Baker A.R., Sindelar W.F., Danforth D.N., Topalian S.L., et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J. Clin. Oncol. 16 (1998) 197-203